Jonathan R. Davies, Ph.D., practices patent litigation, focusing on pharmaceutical, biotechnology, and chemical cases, including Hatch-Waxman litigation related to Abbreviated New Drug Applications (ANDA) and biologics litigation under the Biologics Price Competition and Innovation Act (BPCIA).
Jonathan’s litigation experience includes all aspects of pre-trial and trial district court practice. Jonathan also has experience with patent prosecution and advising clients in infringement and validity opinions.
Jonathan serves as an adjunct professor at American University, Washington College of Law, where he teaches a course on ANDA litigation and biosimilars litigation under BPCIA. Prior to joining Finnegan, Jonathan completed graduate studies in human physiology and conducted doctoral and post-doctoral research in cellular and molecular biology and genetics.
His research focused on molecular mechanisms that regulate cellular growth and division, as well as the regulation of nuclear transport within cells. Jonathan’s pro bono practice includes representing a mother in a child custody case in D.C. Superior Court. He represented a student in litigation related to the improper destruction of his home in D.C. Superior Court and U.S. District Court for the District of Columbia.
The Ohio State University, Moritz College of Law J.D., magna cum laude, 2008
The Ohio State University Ph.D., Molecular Genetics, 2004
Pennsylvania State University M.S., Physiology, 1999